Indefinite Delivery Contract 75N93021D00037
- Not listed
- The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a single award indefinite delivery contract to American Type Culture Collection to provide preclinical services supporting the development of biopharmaceutical therapeutics and diagnostics for infectious diseases. With a potential value of $30 million and a period of performance from January 2023 through September 2030, the contract enables task orders to be issued across five areas: product...
- This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to the American Type Culture Collection (ATCC), a non-profit organization. The $136.6 million contract, with a period of performance through September 2035, is for evaluation and testing services (ETS) related to vaccines and other biologics for infectious diseases. ATCC, a leading provider of biological materials and services to federal agencies,...
- The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a multiple award indefinite delivery contract to the American Type Culture Collection for in vitro assessments of antimicrobial activity and related biological products and services. The master contract has a potential value of $30 million over its period of performance from January 2019 to January 2026. Two task orders have been issued against the contract to date. A $3.08 million order was awarded...
- The Department of Health and Human Services, through the National Institute of Allergy and Infectious Diseases (NIAID), awarded a single-award Indefinite Delivery Contract valued at $146.3 million to the American Type Culture Collection (ATCC), a nonprofit organization, to provide a range of preclinical infectious disease models and specialized reagents. The contract aims to support the development, refinement, and utilization of animal and animal replacement models to evaluate candidate medical...
- The American Type Culture Collection (ATCC), doing business as Atcc, was awarded an indefinite delivery/indefinite quantity contract by the National Institute of Allergy and Infectious Diseases to provide in vitro assessments of antimicrobial activity. The multiple award contract has a potential value of $30 million to be delivered through January 2026 in support of the National Institutes of Health's infectious disease research programs. Under the first delivery order valued at $2,500, Atcc...
- The American Type Culture Collection (ATCC), doing business as Atcc, was awarded an indefinite delivery/indefinite quantity contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide in vitro assessments of antimicrobial activity. The multiple award contract has a potential value of $30 million and period of performance through January 2026. ATCC received a $2,500 delivery order against this master contract for assessments to take place at...
- The National Institute of Allergy and Infectious Diseases has awarded an indefinite delivery contract with a potential value of $107,274,471 to multiple prime contractors to provide preclinical development support for candidate products and drug development activities ranging from initial product discovery to activities required for clinical trials and product licensure. Task orders will be issued under seven task areas, including in vitro testing, synthesis of therapeutic agents, small animal...
- The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to PPD Development LP with a potential value of $545,452,906 to provide comprehensive and rapid response capabilities for research programs through September 2028. Task orders issued against the contract include over $132 million for clinical trial management support services relating to COVID-19, as well as orders valued at $2.33 million, $2 million, and $82.5...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to Lovelace Biomedical Research Institute on September 1, 2021 with a potential value of $545,452,906. Under the terms of the contract, Lovelace Biomedical Research Institute will provide a broad range of services to support biomedical research conducted by NIAID, including clinical trials, manufacturing and controls, nonclinical animal studies, analytics,...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to Emory University to support research efforts from March 2020 through March 2027. Task orders issued against this IDV include delivery of unspecified research services and products related to advancing the understanding and treatment of allergies and infectious diseases. Task order values range from approximately $18,000 to over $11.5 million, with total potential...
- 75N93021D00037Indefinite Delivery Contract
- 2Federal Contract Awards
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a single award Indefinite Delivery Contract to the American Type Culture Collection to provide a quality-assured central repository for the acquisition, authentication, storage, inventory, and distribution of a broad range of biological materials. The contract has a potential value of $545,452,906 over a seven year ordering period ending August 2028. Under the contract, two delivery orders have been awarded to American Type Culture Collection. The first, valued at $6,084,039, spans from September 2023 through September 2030 and tasks the contractor to provide biological materials and related services to support Task Area E. The second, a firm fixed price order valued at $2,000, runs from September 2021 through August 2028 for unspecified products or services. The original pre-solicitation sought proposals for an Indefinite Delivery Indefinite Quantity contract to provide a wide range of services to support biomedical research at the National Institute of Allergy and Infectious Diseases, including clinical trials, manufacturing, animal studies, analytics, and basic research. Offerors were required to demonstrate expertise in areas such as clinical research, vaccine development, and intramural laboratory support. The partially set-aside contract was intended to address research demands over a seven year period from May 2021 through April 2028.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Other Administrative Action | $0 | 7/5/23 | |
| P00001 | Other Administrative Action | $0 | 7/6/22 | |
| Not listed | Not listed | $0 | 8/31/21 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 75N93021D00037-75N93021F00001 | American Type Culture Collection | $2.0k | 9/1/21 | 8/31/28 | 8/31/21 | |
Delivery Order 75N93021D00037-75N93023F00001 | American Type Culture Collection | $6.1m | 9/27/23 | 9/26/26 | 9/4/25 |